Divakaran S, Krawisz A, Secemsky E, Kant S
Arterioscler Thromb Vasc Biol. 2023; 43(11):2099-2114.
PMID: 37706319
PMC: 10615869.
DOI: 10.1161/ATVBAHA.123.319399.
Holder T, Gutierrez J, Aday A
Cardiol Clin. 2021; 39(4):471-482.
PMID: 34686260
PMC: 8544815.
DOI: 10.1016/j.ccl.2021.06.001.
Bath J, Lawrence P, Neal D, Zhao Y, Smith J, Beck A
J Vasc Surg. 2020; 73(5):1693-1700.e3.
PMID: 33253869
PMC: 8189641.
DOI: 10.1016/j.jvs.2020.10.067.
Olivieri B, Yates T, Vianna S, Adenikinju O, Beasley R, Houseworth J
Semin Intervent Radiol. 2019; 35(5):406-426.
PMID: 30728657
PMC: 6363558.
DOI: 10.1055/s-0038-1676342.
Pagidipati N, Navar A, Pieper K, Green J, Bethel M, Armstrong P
Circulation. 2017; 136(13):1193-1203.
PMID: 28626088
PMC: 5614823.
DOI: 10.1161/CIRCULATIONAHA.117.027252.
Building a Critical Limb Ischemia Program.
Galmer A, Selim S, Giri J, Lau J, Weinberg M
Curr Treat Options Cardiovasc Med. 2016; 18(8):50.
PMID: 27289583
DOI: 10.1007/s11936-016-0476-4.
Management of Critical Limb Ischemia.
Kinlay S
Circ Cardiovasc Interv. 2016; 9(2):e001946.
PMID: 26858079
PMC: 4827334.
DOI: 10.1161/CIRCINTERVENTIONS.115.001946.
Intermittent claudication due to peripheral artery disease: best modern medical and endovascular therapeutic approaches.
Kobayashi T, Parikh S, Giri J
Curr Cardiol Rep. 2015; 17(10):86.
PMID: 26280273
DOI: 10.1007/s11886-015-0643-3.
Adherence to guideline-recommended therapy is associated with decreased major adverse cardiovascular events and major adverse limb events among patients with peripheral arterial disease.
Armstrong E, Chen D, Westin G, Singh S, McCoach C, Bang H
J Am Heart Assoc. 2014; 3(2):e000697.
PMID: 24721799
PMC: 4187469.
DOI: 10.1161/JAHA.113.000697.
Peripheral arterial disease: Epidemiology, natural history, diagnosis and treatment.
Dhaliwal G, Mukherjee D
Int J Angiol. 2012; 16(2):36-44.
PMID: 22477268
PMC: 2733014.
DOI: 10.1055/s-0031-1278244.
2011 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Artery Disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice....
Rooke T, Hirsch A, Misra S, Sidawy A, Beckman J, Findeiss L
J Am Coll Cardiol. 2011; 58(19):2020-45.
PMID: 21963765
PMC: 4714326.
DOI: 10.1016/j.jacc.2011.08.023.
2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice....
Rooke T, Hirsch A, Misra S, Sidawy A, Beckman J, Findeiss L
Catheter Cardiovasc Interv. 2011; 79(4):501-31.
PMID: 21960485
PMC: 4505549.
DOI: 10.1002/ccd.23373.
Peripheral artery disease. Part 2: medical and endovascular treatment.
Weinberg M, Lau J, Rosenfield K, Olin J
Nat Rev Cardiol. 2011; 8(8):429-41.
PMID: 21670746
DOI: 10.1038/nrcardio.2011.81.
Profile of cardiovascular risk factors and mortality in patients with symptomatic peripheral arterial disease.
Zanati S, Mouraria G, Matsubara L, Giannini M, Matsubara B
Clinics (Sao Paulo). 2009; 64(4):323-6.
PMID: 19488590
PMC: 2694468.
DOI: 10.1590/s1807-59322009000400010.
Pharmacological treatment of patients with peripheral arterial disease.
Kim C, Schmalfuss C, Schofield R, Sheps D
Drugs. 2003; 63(7):637-47.
PMID: 12656644
DOI: 10.2165/00003495-200363070-00002.
Intermittent Claudication.
Hirsch A, Reich L
Curr Treat Options Cardiovasc Med. 2001; 3(3):167-180.
PMID: 11341862
DOI: 10.1007/s11936-001-0035-4.
The benefits of stopping smoking and the role of nicotine replacement therapy in older patients.
Gourlay S, Benowitz N
Drugs Aging. 1996; 9(1):8-23.
PMID: 8818582
DOI: 10.2165/00002512-199609010-00002.
Intermittent claudication. An update on management.
Blombery P
Drugs. 1987; 34(3):404-10.
PMID: 3315623
DOI: 10.2165/00003495-198734030-00006.
Unsuccessful outpatient counselling to help patients with peripheral vascular disease to stop smoking.
Power L, Brown N, Makin G
Ann R Coll Surg Engl. 1992; 74(1):31-4.
PMID: 1736792
PMC: 2497487.